Genentech's first campaign for eye disease treatment Vabysmo features eye-catching images.
Roche’s Genentech debuts first consumer effort for diabetes and age-related eye disease drug
Genentech’s first campaign for eye drug Vabysmo is literally eye-opening.
In the debut TV commercial, a woman opens an eye-shaped screen, stepping through into different …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
